Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2020-12-03 | 2021-05-20 | 129530 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Resolved | 2021-05-13 | 2021-05-14 | 139303 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138300 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138294 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2021-04-21 | 2021-05-13 | 137893 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-03-25 | 2021-05-13 | 136317 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-02-18 | 2021-05-13 | 134343 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-04-08 | 2021-05-13 | 137185 |
| ACT CELECOXIB | 200MG | CAPSULE | Actual shortage | 2021-02-18 | 2021-05-06 | 134357 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120309 |
| TEVA-CAPTOPRIL | 50MG | TABLET | Resolved | 2021-04-29 | 2021-05-06 | 138303 |
| TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2021-04-29 | 2021-05-06 | 138288 |
| ACT DEXTROAMPHETAMINE SR | 10MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-03-25 | 2021-05-06 | 136292 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2021-03-18 | 2021-05-06 | 135949 |
| TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2021-03-11 | 2021-05-06 | 135555 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2021-02-25 | 2021-05-06 | 134749 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2021-01-22 | 2021-05-06 | 132276 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2021-01-15 | 2021-05-06 | 131691 |
| TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2019-08-22 | 2021-05-06 | 92171 |
| TEVA-AMPHETAMINE XR | 15MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-01-15 | 2021-05-06 | 131679 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |